References
- 정재훈 : 의약분업 이후 제약기업의 경제지표 분석. 성균관대학교. 석사 (2011).
- Smith, B. D. : The future of pharma. Part 2 Co-evolving industry (2011).
- 한국보건산업진흥원 : 글로벌 제약회사의 환경변화 (2010).
- Docteur, E. : Pharmaceutical pricing policies in a global market. OECD Health Policy Studies, Paris (2007).
- Leopold, C., Vogler, S., Mantel-Teeuwisse, A. K., de Joncheere, K., Leufkens, H. G. and Laing, R. : Differences in external price referencing in europe: a descriptive overview. Health Policy 104, 50 (2012).
- Malhotra, P. : Impact of TRIPS in India- An Access to Medicines Perspectives. Part 1. Influence of global forces on access to medicines (2010).
- Scherer, F. M. : The pharmaceutical industry--prices and progress. N. Engl. J. Med. 351, 927 (2004).
- Smith, B. D. : The future of pharma. Part 1. A stalling industry. (2011).
- IMS Health Data: Global Pharma Forecast Pack (2010).
- 연세대학교 : 국내 의약품 선진시장 진출 방안을 위한 워크샵. 서울 (2011).
- Garattini, L. and Tediosi, F. : A comparative analysis of generics markets in five European countries. Health Policy 51, 149 (2000).
- Department of Pharmaceuticals: Annual Report, Government of India (2009-2010).
- Infodrive India. India Export Import. Available at: http://www.infodriveindia.com/export-import/trade-statistics/topproduct. aspx. Accessed August 11 (2011).
- Business Maps of India. Indian Pharmaceutical Industry. Available at: http://business.mapsofindia.com/pharmaceutical. Accessed Feb 2 (2012).
- Greene, W. : The Emergence of India's Pharmaceutical Industry and Implications for the U.S. Generic Drug Market. Office of Economics working paper No.2007-05-A, U.S. International Trade Commission (2007).
- 한국의약품수출입협회. Available at: http://www.kpta.or.kr/export/export_03.asp. Accessed August 18 (2011).
- Kim, H. J., Chung, W. and Lee, S. G. : Lessons from Korea's pharmaceutical policy reform: the separation of medical institutions and pharmacies for outpatient care. Health Policy 68, 267 (2004).
- Malhotra, P. and Lofgren, H. : India's pharmaceutical industry: hype or high tech take-off? Aust. Health Rev. 28, 182 (2004).
- Singh, S. : Indian pharma enters the global arena. Cell. 128, 811 (2007).
- 강예규 : 한국의약품의 현황과 수출증대방안. 성균관대학교. 석사 (2000).
- 김용후 : 한미자유무역협정 추진현황과 전망. 성균관대학교. 석사 (2006).
- 문상호 : 보건의료정책과 거버넌스. 국정관리연구 2, 163 (2007).
- 박지현 : 한미FTA 속의 TRIP-Plus. 국제법학회논총 53, 85 (2008).
- 한국식품의약품안전청. Available at: http://www.kfda.go.kr/index. kfda?mid=56&seq=13099 Accessed Aug 14 (2011).
- Kripalani, M. : Pharma Karma; Tougher patent protection laws are spurring rapid growth in new drug research across India. Business Week 39, 20 (2005).
- 임세호 : GMP 선진화 절실 아닌 '시급'. 약업신문, 서울 (2007).
- IMS Health Data MIDAS: Market Prognosis (2010).
- Dong-A Pharmaceutical: Annual Report (2010).
- Ranbaxy: Annual Report (2010).
- The Korean Society for Microbiology and Biotechnology. 바이 오시밀러: 해결해야 할 과제. Available at: http://www.kormb.or.kr/home/kor/Newsletter/Files/.../101125_162015626.pdf Accessed August 8 (2011).
- Labotaroties, I. : Annual Report (2010-2011).
- Cadila, Z. : Annual Report (2010-2011).
- Aurobindo : Annual Report (2010-2011).
- Limited, L. : Annual Report (2009-2010).
- Sun Pharmaceuticals : Annual Report (2009-2010).
- Cipla : Annual Report (2009-2010).
- Dr. Reddy : Annual Report (2010-2011).
- 한미약품 : 2010년도 사업보고서.
- 유한양행 : 2010년도 사업보고서.
- 지식경제부 홈페이지. Available at: http://www.mke.go.kr/policy/future/future0101.jsp Accessed Feb 8 (2012).
- 식품의약품안전청 홈페이지. Available at: http://www.kfda.go.kr/ index.kfda?mid=56&seq=16928&cmd=v Accessed Feb 8 (2012).
- Datta J. More global buys by pharma cos likely. Available at: http://www.thehindubusinessline.in/2005/07/22/stories/2005072202240300.htm Accessed Aug 17 (2011).
- 바이오 2008을 통해 본 세계 바이오산업 동향 및 전망. 보건산업정책 Issue Report 2008-6 (2008).
- Malhotra, H. : Biosimilars and non-innovator biotherapeutics in India: an overview of the current situation. Biologicals 39, 321 (2011).
- 김태억 : 바이오시밀러 산업동향과 국내기업의 진입전략. Available at: http://k2b.biz/298 Accessed Aug 15 (2011).
- 한국산업마케팅연구소. 바이오의약 산업동향과 바이오시밀러 비즈니스 성공전략. Available at: http://www.bioin.or.kr/board.do?num=172034&cmd=view&bid=industry Accessed July 25 (2011).
- 고유상 : 세계 바이오제약산업의 M&A 동향. SERI 경제포커스. 삼성경제연구소 (2007).
- 식품의약품안전청. 제 18호 국내개발 신약 '슈펙트캡슐' 허가. Available at: http://www.kfda.go.kr/index.kfda?mid=56&seq= 16779&cmd=v. Accessed Jan 30 (2012).
- 식품의약품안전청. 2011년 상반기 천연물신약 개발 활기. Available at: http://www.kfda.go.kr/index.kfda?mid=56&seq= 15568&cmd=v Accessed Aug 14 (2011).
- Federal Register. 75(176) (2010).
- Simoens, S. : Health economics of market access for biopharmaceuticals and biosimilars. Journal of Medical Economics 12, 211 (2009).